Skip to content

Extension of the MIME Robotic System for Stroke Rehabilitation

Extension of the MIME Robotic System for Stroke Rehabilitation

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00995774
Enrollment
12
Registered
2009-10-15
Start date
2010-06-30
Completion date
2012-05-31
Last updated
2018-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Impaired Upper Extremity Function

Keywords

stroke, function, arm, hand, robotic, therapy, motor, movement, treatment

Brief summary

The goal of this project is to develop and test a new robotic system to accommodate practice of tasks requiring reach, grasp and release of objects. Our previous work has shown that the MIME robot is safe and effective for improving reach in stroke subjects. But adequate control of hand movements is critical to a functional upper limb, and is often resistant to conventional therapeutic interventions. Many stroke survivors have residual ability to flex the fingers, but extension is often limited and impeded by increased passive stiffness in flexors, abnormal levels of increased tone in flexors and weakness in extensors. In a recent study, 38% of stroke survivors reported that impaired hand function was the most disabling motor impairment they faced.

Detailed description

Research Design: We hypothesize that: 1) Gains in proximal arm function (shoulder, elbow) immediately after robotic training will be greater than after dose-matched conventional therapy; 2) Unlike in previous studies, gains in hand function immediately after robotic training will be greater than after dose-matched conventional therapy. Methodology: In the first year of the study, we will develop a robotic system with the ability to assist hand movement. Since many stroke survivors in the subacute and chronic recovery stages have residual ability to flex the fingers but severely limited finger extension, we will build a hand exoskeleton that can apply precise extension forces to the digits of the hand. This exoskeleton will be integrated with the ARMin III arm exoskeleton so that tasks such as arm reach, grasp of an object and release of the object can be trained. In the last 2 years of the project, we will perform a pilot clinical trial comparing this new training paradigm to dose-matched conventional therapy in chronic stroke survivors. Outcome measures will be taken before training and immediately after training.

Interventions

12 sessions of robot therapy for arm and hand function

OTHERconventional functional training

12 sessions of conventional therapy for the arm and hand from a physical therapist

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* An ischemic or hemorrhagic stroke more than 6 months prior to entry into the study; * trace ability to move the wrist and fingers in extension; * voluntary shoulder elevation to approximately 45 deg; * be between the ages of 21 and 90.

Exclusion criteria

* Have cognitive deficits that could negatively affect their ability to complete protocols as evidenced by a score of 24 or less on the Folstein Mini - Mental State Examination (Bleeker, 1988); * have excessive pain in any joint of the affected extremity that could limit ability to cooperate with the protocols; * have an upper extremity injury or conditions prior to stroke that could limit participation; * have severe hemispatial neglect. * have a full score of 24 on the distal section of the Fugl-Myer test (FM) (Fugl-Meyer 1975); and * have severe sensory loss.

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Test of Motor Functionbefore Training Period 1, after Training Period 1, before Training Period 2, after training Period 2This scale assesses motor impairments at the shoulder, elbow, wrist and fingers (Fugl-Meyer 1975). Individual subscores are added to create a total score that ranges from 0 to 66 points. A score of 66 indicates no impairment.

Secondary

MeasureTime frameDescription
Action Research Arm Testbefore Training Period 1, after Training Period 1, before Training Period 2, after training Period 2This scale is a standardized assessment of functional limitations in the upper extremity. Individual subscores are summed to create a total score that ranges from 0 to 57 points. A score of 57 indicates no functional limitations.
A Motion Analysis Evaluation Will be Performed on Reach and Grasp Tasks. The Kinematics Will be Measured Using an Electromagnetic Tracker (Flock of Birds, Ascension Technology Corp., Burlington VT).pre-treatment, post treatment

Countries

United States

Participant flow

Recruitment details

Recruitment was through word of mouth with therapists at the outpatient clinics of the DC Veterans Affair Medical Center and the MedStar National Rehabilitation Hospital. Recruitment took place approximately between 9/2010 and 3/2012.

Pre-assignment details

Fourteen individuals were recruited. One subject was excluded due to a prior orthopedic injury and another subject did not meet the Folstein Mini-Mental State Examination criterion. Two subjects completed the protocol up through the initial training period and the washout period, but did not return for the second therapy block.

Participants by arm

ArmCount
Robotic Then Conventional
12 hours of robotic arm therapy, followed by a 1 month washout period, followed by 12 hours of conventional arm therapy with a physical therapist
7
Conventional Then Robotic
12 hours of conventional arm therapy with a physical therapist, followed by a 1 month washout period, followed by 12 hours of robotic arm therapy
5
Total12

Withdrawals & dropouts

PeriodReasonFG000FG001
Training Period 2Withdrawal by Subject20

Baseline characteristics

CharacteristicConventional Then RoboticRobotic Then ConventionalTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants3 Participants4 Participants
Age, Categorical
Between 18 and 65 years
4 Participants4 Participants8 Participants
Age, Continuous57.8 years
STANDARD_DEVIATION 16.3
57.7 years
STANDARD_DEVIATION 10.8
57.7 years
STANDARD_DEVIATION 12.2
Region of Enrollment
United States
5 Participants7 Participants12 Participants
Sex: Female, Male
Female
0 Participants3 Participants3 Participants
Sex: Female, Male
Male
5 Participants4 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 70 / 5
serious
Total, serious adverse events
0 / 70 / 5

Outcome results

Primary

Fugl-Meyer Test of Motor Function

This scale assesses motor impairments at the shoulder, elbow, wrist and fingers (Fugl-Meyer 1975). Individual subscores are added to create a total score that ranges from 0 to 66 points. A score of 66 indicates no impairment.

Time frame: before Training Period 1, after Training Period 1, before Training Period 2, after training Period 2

ArmMeasureGroupValue (MEAN)Dispersion
Robotic Then ConventionalFugl-Meyer Test of Motor FunctionChange from beginning to end of training period 11.9 units on a scaleStandard Deviation 4.6
Robotic Then ConventionalFugl-Meyer Test of Motor FunctionChange from beginning to end of washout period1.3 units on a scaleStandard Deviation 4.4
Robotic Then ConventionalFugl-Meyer Test of Motor FunctionChange from beginning to end of training period 21.6 units on a scaleStandard Deviation 3.6
Conventional Then RoboticFugl-Meyer Test of Motor FunctionChange from beginning to end of training period 1.8 units on a scaleStandard Deviation 2.9
Conventional Then RoboticFugl-Meyer Test of Motor FunctionChange from beginning to end of washout period.8 units on a scaleStandard Deviation 3.9
Conventional Then RoboticFugl-Meyer Test of Motor FunctionChange from beginning to end of training period 21.6 units on a scaleStandard Deviation 2.3
Secondary

Action Research Arm Test

This scale is a standardized assessment of functional limitations in the upper extremity. Individual subscores are summed to create a total score that ranges from 0 to 57 points. A score of 57 indicates no functional limitations.

Time frame: before Training Period 1, after Training Period 1, before Training Period 2, after training Period 2

ArmMeasureGroupValue (MEAN)Dispersion
Robotic Then ConventionalAction Research Arm TestChange from beginning to end of training period 14.6 units on a scaleStandard Deviation 3.5
Robotic Then ConventionalAction Research Arm TestChange from beginning to end of washout period.4 units on a scaleStandard Deviation 2.9
Robotic Then ConventionalAction Research Arm TestChange from beginning to end of training period 2-2 units on a scaleStandard Deviation 5.9
Conventional Then RoboticAction Research Arm TestChange from beginning to end of training period 1-.2 units on a scaleStandard Deviation 1.1
Conventional Then RoboticAction Research Arm TestChange from beginning to end of washout period0 units on a scaleStandard Deviation 1.6
Conventional Then RoboticAction Research Arm TestChange from beginning to end of training period 21.4 units on a scaleStandard Deviation 3
Secondary

A Motion Analysis Evaluation Will be Performed on Reach and Grasp Tasks. The Kinematics Will be Measured Using an Electromagnetic Tracker (Flock of Birds, Ascension Technology Corp., Burlington VT).

Time frame: pre-treatment, post treatment

Population: Data initially collected but could not interpret results due to a lack of resources and incomplete data analysis. No further staff, tools, or information is available to report conclusions.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026